Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcystine [correction of acetylcystine] therapy
about
Heparin for the treatment of burnsNebulized heparin for patients under mechanical ventilation: an individual patient data meta-analysisDiagnosis and management of inhalation injury: an updated reviewAssessing inhalation injury in the emergency roomClinical review: the critical care management of the burn patientDoes a Nebulized Heparin/N-acetylcysteine Protocol Improve Outcomes in Adult Smoke Inhalation?Intratracheal heparin improves plastic bronchitis due to sulfur mustard analog.Influence of inhalation injury on energy expenditure in severely burned children.Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review.Current pharmacotherapy for the treatment of severe burns.Heparin reduced mortality and sepsis in severely burned childrenBlood gases as an indicator of inhalation injury and prognosis in burn patients.Pediatric burns: the forgotten trauma of childhood.Intensive care management and control of infectionTissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction.Inhalation injury: epidemiology, pathology, treatment strategies.Use of inhaled heparin/N-acetylcystine in inhalation injury: does it help?Management of burn injuries--recent developments in resuscitation, infection control and outcomes research.Pharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease.Pathophysiology, management and treatment of smoke inhalation injury.The evaluation and management of thermal injuries: 2014 update.Pharmaco-management of inhalation injuries for burn survivors.A survey of current practices in the diagnosis of and interventions for inhalational injuries in Canadian burn centres.HEPBURN - investigating the efficacy and safety of nebulized heparin versus placebo in burn patients with inhalation trauma: study protocol for a multi-center randomized controlled trial.Mechanical ventilation after injury.Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome.Coagulopathy and its management in patients with severe burns.Pathophysiology, research challenges, and clinical management of smoke inhalation injury.Progress in burns research: a review of advances in burn pathophysiology.Inhalation Injury: Pathophysiology, Diagnosis, and Treatment.High-Frequency Ventilation Modalities as Salvage Therapy for Smoke Inhalation-Associated Acute Lung Injury: A Systematic Review.Outcomes Following the Use of Nebulized Heparin for Inhalation Injury (HIHI Study).Recurrent Obstructive Fibrinous Tracheal Pseudomembranes in a Young English Bulldog.Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injury.Aerosolised heparin in the treatment of Fontan-related plastic bronchitis.Nebulized anticoagulants in lung injury in critically ill patients-an updated systematic review of preclinical and clinical studies.Bronchoalveolar lavage analysis in victims of severe facial burns.The use of pulmonary clearance medications in the acutely ill patient.Inhalation Injury in the Burned Patient.Fifty Years of Burn Care at Shriners Hospitals for Children, Galveston.
P2860
Q24234744-40EA374F-3D7A-47D0-8004-36BDE7E0133AQ26753103-063A7199-41B7-4481-A568-03BB0112B28DQ26778364-D33EE91F-2C0F-4D54-9E5E-329B614F4745Q27022736-C77315E5-9185-4F52-95CF-43B3BA94F3F7Q33754729-190E610D-5659-4A0A-AFAA-24BF2AB2BCD5Q34239772-EABF54A2-2F13-41DD-80D2-BA7CDB98886FQ34276253-B26BA161-04E8-42DD-82BC-5B2E3B9F486BQ34604007-BD030411-F750-4B23-9F77-2B16D4A9D1A2Q35026021-DB9BF797-0565-44C7-B520-B3AD1171D41EQ35076594-FFB7BF2D-780D-450F-9B0A-AF36D844C09BQ35279561-AE4C096C-B7BB-4779-8837-94211CC0F3CDQ35280475-0B7790E7-DBB4-4B68-841D-B2A2721D570DQ35517202-07B9A4BD-8D33-4EB7-8AAE-F65238FE8AD0Q35844646-1CBA8394-AF7B-4844-BEB8-EBCAE41C8A6FQ36842960-4AAD34C7-A3F2-4ACF-A27D-6BFB8A0CB579Q36843532-8E979D0A-9C2D-47C7-B53B-C270A05CF735Q37053482-1A664BB8-7C99-4816-BF08-F7F4441B2E8FQ37152935-6F35BEE1-7A08-406D-846E-E8EDAACB446CQ37179472-3F1274F1-0D82-4A61-8EBD-EF312F18A6FEQ37292497-EFBEEFFE-6798-4C02-B83B-096DB23EC6B6Q37315475-EA59D13D-B7BA-4861-A21F-B49B8BB0B2FAQ37385598-F127AA33-64C8-4567-B65A-B2C7402FA437Q37543522-0ED41A2A-8579-4E55-B943-0AC0A1F95203Q37704781-4A196143-99A2-4C70-AE29-2961E815B884Q38041540-5CDD3914-40C7-49BF-BB73-647A7C538052Q38056776-03D505A7-9E96-481F-9820-A11319E7911EQ38725913-06FE9171-579C-428B-905D-73428AEBFD79Q38814534-4E9446E1-6CA9-473A-8BAA-4E3EFA0C52F2Q38851267-44B738C2-6620-4A20-B052-F98DC3163212Q39346933-3A312421-A5A0-460E-BBFF-89370A86C020Q39398914-3D6EDD3F-CB15-4765-8BFA-AB4EC87DD488Q39482638-8349DBE4-0422-4520-AE79-BEB38651273EQ42315928-808A5ADD-C83C-4238-8F5A-9B44FC8249A1Q42764805-9F1C2F5E-4936-4D2B-8828-49406CF233DFQ44982321-A36328CE-A5B1-43EA-BF47-7E5C40961B31Q47097092-62F5058E-0B62-4787-8F09-79C73B2B7A1FQ47733585-F8EFFC1A-21E9-4DFB-A3B0-73BE39F04046Q47810242-3729F26D-0A4D-44A3-8188-4C6E74E4B987Q49814779-B60CEB60-B076-4A69-936B-B3EBB059ADCCQ49814788-C84074C8-4DB9-47BB-9AA3-8A3D33E5D05A
P2860
Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcystine [correction of acetylcystine] therapy
description
1998 nî lūn-bûn
@nan
1998 թուականին հրատարակուած գիտական յօդուած
@hyw
1998 թվականին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Reduction in mortality in pedi ...... tion of acetylcystine] therapy
@ast
Reduction in mortality in pedi ...... tion of acetylcystine] therapy
@en
Reduction in mortality in pedi ...... tion of acetylcystine] therapy
@nl
type
label
Reduction in mortality in pedi ...... tion of acetylcystine] therapy
@ast
Reduction in mortality in pedi ...... tion of acetylcystine] therapy
@en
Reduction in mortality in pedi ...... tion of acetylcystine] therapy
@nl
prefLabel
Reduction in mortality in pedi ...... tion of acetylcystine] therapy
@ast
Reduction in mortality in pedi ...... tion of acetylcystine] therapy
@en
Reduction in mortality in pedi ...... tion of acetylcystine] therapy
@nl
P2093
P3181
P1476
Reduction in mortality in pedi ...... tion of acetylcystine] therapy
@en
P2093
P3181
P356
10.1097/00004630-199805000-00004
P407
P577
1998-01-01T00:00:00Z